Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
07/2009
07/08/2009EP1371730B1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
07/08/2009CN101474210A Preparation method of lactobacillus oligopeptide oral liquid
07/08/2009CN101474209A Preparation method of enzyme induced bezoar
07/08/2009CN101474208A Classification and production technique of newborn calf serum
07/08/2009CN101474207A Method for overcoming adverse effect of pre-existing immunoreaction to AD virus vector product and use thereof
07/08/2009CN100510060C Method of extended culture for antigen-specific cytotoxic t lymphocytes
07/08/2009CN100510056C Bifidobacterium and application thereof
07/08/2009CN100510055C Acidophilic lactobacillus and application thereof
07/08/2009CN100508994C No-cell calmette-Guerin bacillus mucosa immune regulator and application thereof
07/08/2009CN100508993C Enterobacteria containing tablet
07/08/2009CN100508992C Chinese medicine for treating trauma, burns and scalds
07/08/2009CN100508991C Biological fat-reducing health product and preparation method thereof
07/08/2009CN100508968C Avian appeasing pheromones to decrease stress, anxiety and aggressiveness
07/08/2009CN100508943C Substance capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof
07/07/2009US7557188 von Willebrand factor; von Willebrand's disease, phenotypic hemophilia, hemophilia A and factor VIII inhibitors
07/07/2009US7557182 Drug delivery across the blood-brain barrier using polypeptides; neurological diseases; aprotinin
07/07/2009US7557094 Complex of chitosan, conjugated linoleic acid, vitamin a and cyclodextrin
07/07/2009US7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its use
07/07/2009US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy
07/07/2009US7556803 Using kappa-myeloma antigen specific immunoglobulins to target and destroy tumor cells; immunotherapy
07/07/2009US7556801 Pluripotent somatic stem cells for use in regenerative medicine; use in treatment of vascular disease, Parkinson's disease, diabetes
07/07/2009US7556796 Pproducing a tumorigenic mouse cell by introducing into the cell containing a recombinant oncogene operably linked to an inducible promoter, a recombinant gene of interest that functionally complements the oncogene and restores tumorigenicity without expression of the inducible recombinant oncogene
07/07/2009US7556649 Methods and compositions for treating intervertebral disc degeneration
07/07/2009CA2201161C Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof
07/07/2009CA2167692C Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
07/02/2009WO2009082648A1 Stabilized factor ix formulations containing trehalose
07/02/2009WO2009082227A1 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent
07/02/2009WO2009081395A1 A method of treating neurodegenerative diseases
07/02/2009WO2009080914A2 Method for stimulating the proliferation of differentiated cells belonging to the chondrogenic lineage
07/02/2009WO2009080857A1 Method for obtaining melanins and use thereof
07/02/2009WO2009080800A2 Method for decreasing abdominal girth by administering a bifidobacterium bacteria
07/02/2009WO2009080767A1 Fish vaccine
07/02/2009WO2009080749A1 Human bone-forming cells in the treatment of inflammatory rheumatic diseases
07/02/2009WO2009079822A1 A bcg polysaccharide nucleic acid extractive and preparation method thereof
07/02/2009WO2009079693A1 Design and selection of medicaments that modulate the function and activity of interleukin 13
07/02/2009WO2009058898A3 Method and apparatus for diagnoses of hemangiosarcoma in mammals
07/02/2009WO2009053631A3 Method for optimizing blood cell transplants
07/02/2009WO2009053629A3 Treatment of tumours using t lymphocyte preparations
07/02/2009WO2008142198A3 A method for inhibiting or stimulating angiogenesis in an individual
07/02/2009US20090171406 Electrically conducting scaffolds for cell-based pacing
07/02/2009US20090170763 Modified gherlin peptides
07/02/2009US20090170758 Compositions comprising pulmonary surfactants and a polymyxin having improved surface properties
07/02/2009US20090170197 Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)
07/02/2009US20090170193 Stem cells
07/02/2009US20090170191 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
07/02/2009US20090169642 Reconstructed living adipose tissue
07/02/2009US20090169597 Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells
07/02/2009US20090169596 Device for spinal cord nerve regeneration
07/02/2009US20090169592 Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
07/02/2009US20090169586 Stable packaged dosage form and process therefor
07/02/2009US20090169580 Attenuated vaccines for non-segmented negative sense rna viruses
07/02/2009US20090169573 T-Cell Stimulatory Peptides From The Melanoma-Associated Chondroitin Sulfate Proteoglycan And Their Use
07/02/2009US20090169566 Bioactive compositions
07/02/2009US20090169563 Administering monoclonal antibody or an antigen-binding portion thereof that specifically binds to and activates human CD40; Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
07/02/2009US20090169543 Method for regulating immune function in primates using the Foxp3 protein
07/02/2009US20090169532 Curable bone cement
07/02/2009US20090169531 Use of symbiotic for the treatment of atopic dermatitis
07/02/2009US20090169529 Compositions and methods for immunostimulatory rna oligonucleotides
07/02/2009US20090169528 Keratinocytes expressing exogenous angiogenic growth factors
07/02/2009US20090169527 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors
07/02/2009US20090169525 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells
07/02/2009US20090169524 Composites and methods of preparation and use thereof
07/02/2009US20090169523 Hsc self-renewal
07/02/2009US20090169522 Mesenchymal stem cells expressing tnf-a receptor
07/02/2009US20090169520 Compounds, Pharmaceutical Compositions and Therapeutic Methods of Preventing and Treating Diseases and Disorders Associated With Amyloid Fibril Formation
07/02/2009US20090169519 Medicinal formulation containing a combination of hiv type i and hiv type ii
07/02/2009US20090169517 Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules
07/02/2009US20090169516 Method of constructing gene transport support
07/02/2009US20090169515 Canine probiotic bifidobacteria globosum
07/02/2009US20090169514 Expression Vectors Comprising the HS1 Promoter of the VAV1 Oncogene and Use Thereof for the Preparation of Pharmaceutical Compositions Intended for Somatic Gene Therapy
07/02/2009US20090169512 Clonal strain of attenuated vaccinia virus that can be used to prevent or treat small pox
07/02/2009US20090169506 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY
07/02/2009US20090169485 Gene therapy and pharmaceutical composition for prevention and treatment of lung cancer
07/02/2009US20090169476 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
07/02/2009US20090166298 Methods And Apparatus For Controlled Addition Of Solutions To Blood Components
07/02/2009CA2710081A1 Human bone-forming cells in the treatment of inflammatory rheumatic diseases
07/02/2009CA2709662A1 A method of treating neurodegenerative diseases
07/02/2009CA2707032A1 Stabilized factor ix formulations containing trehalose
07/01/2009EP2075332A1 Cytokine production regulator gene and use thereof
07/01/2009EP2075003A1 Parvovirus having a CpG-enriched genome useful for cancer therapy
07/01/2009EP2075002A2 Use of myoblasts in the manufacture of a medicament for treating stress urinary incontinence
07/01/2009EP2074889A1 Animal feed additive and animal feed
07/01/2009EP2073822A1 Processes for preparing fertilized egg components
07/01/2009EP1708575A4 Improved modalities for the treatment of degenerative diseases of the retina
07/01/2009EP1707210A4 Antiviral preparation
07/01/2009EP1675601B1 Moderating the effect of endotoxins
07/01/2009EP1666048A4 Method for producing insulin from a natural source and insulin
07/01/2009EP1567018B1 Method of improving immune function in mammals using lactobacillus reuteri strains
07/01/2009EP1552018B1 Methods and compositions relating to gene silencing
07/01/2009EP1351967B1 Compositions and methods for the therapy and diagnosis of lung cancer
07/01/2009EP1331977B1 Blood centrifuge cup having a replaceable compartment for filter support
07/01/2009EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
07/01/2009EP1080216B1 Retroviral delivery system
07/01/2009EP1019068B1 Therapeutic formulations containing snake and/or insect venom for the prophylaxis and therapy of neoplasms
07/01/2009EP0871748B1 Delivery of biologically active polypeptides
07/01/2009EP0784688B1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
07/01/2009CN101472599A Visceral fat accumulation inhibitor, and agent for promoting the increase in and/or inhibiting the decrease in blood adiponectin level
07/01/2009CN101468045A Spray powder for treating mouth ulcer and preparation method thereof
07/01/2009CN101468044A Formulating method of powder for treating dermatopathy
07/01/2009CN101468043A Method for extracting globulin from terrestrial mollusk and use thereof